User profiles for Jeffrey A. Sparks
 | Jeffrey A. Sparks, MD, MMScAssociate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School Verified email at bwh.harvard.edu Cited by 12884 |
2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
…, JA Singh, BJ Smith, JA Sparks… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
arthritis. Methods We developed clinically relevant population, intervention, comparator, …
Rheumatoid arthritis and mortality among women during 36 years of prospective follow‐up: results from the Nurses' Health Study
… Address correspondence to Jeffrey A. Sparks, MD, MMSc, Department of Medicine, Division
… Sparks had full access to all of the data in the study and takes responsibility for the integrity …
… Sparks had full access to all of the data in the study and takes responsibility for the integrity …
[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …
JA Sparks, ZS Wallace, AM Seet… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …
[HTML][HTML] Persistence and evolution of SARS-CoV-2 in an immunocompromised host
…, MC Choudhary, J Regan, JA Sparks… - … England Journal of …, 2020 - Mass Medical Soc
SARS-CoV-2 in an Immunocompromised Host This letter describes an immunocompromised
patient who had persistent infection with SARS-CoV-2 over a period of months, despite …
patient who had persistent infection with SARS-CoV-2 over a period of months, despite …
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'
…, X Fu, EM Gravallese, HK Choi, JA Sparks… - Annals of the …, 2020 - ard.bmj.com
Objective To investigate differences in manifestations and outcomes of coronavirus disease
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …
A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19
Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions,
has garnered widespread attention as a potential treatment for COVID-19 infection. The …
has garnered widespread attention as a potential treatment for COVID-19 infection. The …
SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an …
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an …
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …
because of their ability to ameliorate shared immune pathways across immune-mediated …